XML 20 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating Activities    
Net income $ 301,677 $ 306,686
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation & amortization 21,994 22,677
(Increase) decrease in value of equity securities (2,121) 6,118
Amortization of securities, net 11,083 12,441
Accretion of purchased loans (6,523) (8,263)
Share-based compensation 6,718 7,076
Gain on assets (2,627) (1,479)
Provision for credit losses - loans 31,700 6,300
Recovery of credit losses - unfunded commitments 0 (1,500)
(Recovery of) provision for credit losses - investment securities (330) 1,683
Deferred income tax effect 686 861
Increase in cash value of life insurance (3,635) (3,485)
Originations of mortgage loans held for sale (467,339) (365,412)
Proceeds from sales of mortgage loans held for sale 477,185 315,520
Changes in assets and liabilities:    
Accrued interest receivable 95 (7,747)
Other assets (26,428) (7,293)
Accrued interest payable and other liabilities 43,405 (20,010)
Net cash provided by operating activities 385,540 264,173
Investing Activities    
Net increase in federal funds sold (1,325) (3,925)
Net (increase) decrease in loans (428,985) 181,505
Purchases of investment securities – available-for-sale (62,643) (8,433)
Proceeds from maturities of investment securities – available-for-sale 363,011 504,220
Proceeds from maturities of investment securities – held-to-maturity 5,054 4,383
Proceeds from sales of equity securities 0 1,522
Purchase of other investments (445) (1,798)
Proceeds from foreclosed assets held for sale 1,475 846
Proceeds from sale of SBA loans 5,573 3,454
Purchases of premises and equipment (24,277) (17,503)
Proceeds from sales of premises and equipment 14,818 10,724
(Purchase of) return of investment on cash value of life insurance, net (1,218) 3,813
Net cash (used in) provided by investing activities (128,962) 678,808
Financing Activities    
Net decrease in deposits (82,001) (1,420,038)
Net increase in securities sold under agreements to repurchase 37,331 28,974
Decrease in FHLB and other borrowed funds (1,400,550) (1,065,000)
Increase in FHLB and other borrowed funds 1,400,000 1,416,550
Proceeds from exercise of stock options, net 1,369 431
Repurchase of common stock (84,036) (31,007)
Dividends paid on common stock (111,227) (109,602)
Net cash used in financing activities (239,114) (1,179,692)
Net change in cash and cash equivalents 17,464 (236,711)
Cash and cash equivalents – beginning of year 1,000,213 724,790
Cash and cash equivalents – end of period $ 1,017,677 $ 488,079